The Fidia Pharma Group

Fidia is part of the P&R Holding, one of the leading Italian groups in the chemical sector, and has a long tradition of top-quality products, fruit of years of careful scientific research.

P&R Holding was established in 2006 and includes several companies operating in different business sectors.
The Group is mainly involved in the R&D, manufacturing, marketing and sales of finished dosage forms and APIs for the pharmaceutical industry. The Group's main objective is to provide clients and customers worldwide with high-quality products, ensuring the highest standards in production, environmental concerns and commercial reliability.

P&R Holding Group

Innovation, competitiveness, internationalization, and quality are P&R's leading principles and a prerequisite for the success of its customers and partners, whereas efficient integration capabilities of the Group's companies help manage business processes and create a stronger portfolio. P&R Holding's daily business is determined by the following core values and principles:
  • High Quality
  • Innovative Technological Expertise
  • Competitiveness in R&D
  • Customer Satisfaction
  • Focus on Human Resources
  • Responsible Partnership

For additional information on P&R, visit www.prholding.it

The Companies part of the Fidia Pharma Group

Fidia and its partners commercialize their products worldwide, either through commercial agreements with selected companies in the pharmaceutical and biomedical sectors or with a direct presence in specific, strategic markets such as USA, Germany, Kazakhstan, Spain, Middle East and Russia.

The Group has other members besides Fidia Farmaceutici s.p.a., all reinforcing its marketing potential:

Health
Products
Website

Find out more about Fidia’s product portfolio:

Go to the website

Fidia worldwide

Direct links to access Fidia’s international websites:


Follow us:

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint healthcare
- advanced wound care
- dermatology
- neurology
- dermo-aesthetics